BRPI0619213B8 - composto precursor de composto orgânico marcado com haloênio radioativo - Google Patents

composto precursor de composto orgânico marcado com haloênio radioativo

Info

Publication number
BRPI0619213B8
BRPI0619213B8 BRPI0619213A BRPI0619213A BRPI0619213B8 BR PI0619213 B8 BRPI0619213 B8 BR PI0619213B8 BR PI0619213 A BRPI0619213 A BR PI0619213A BR PI0619213 A BRPI0619213 A BR PI0619213A BR PI0619213 B8 BRPI0619213 B8 BR PI0619213B8
Authority
BR
Brazil
Prior art keywords
substituent
compound
radioactive
amino acid
halogen
Prior art date
Application number
BRPI0619213A
Other languages
English (en)
Inventor
Hayashi Akio
Harano Arinori
Kurosaki Fumie
Toyama Masahito
Ito Osamu
Shinmura Toshiyuki
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Publication of BRPI0619213A2 publication Critical patent/BRPI0619213A2/pt
Publication of BRPI0619213B1 publication Critical patent/BRPI0619213B1/pt
Publication of BRPI0619213B8 publication Critical patent/BRPI0619213B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/307—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

composto precursor de composto orgânico marcado com halogênio radioativo. a presente invenção tem por objetivo oferecer um novo composto orgânico de aminoácidos que possa ser utilizado como composto precursor para marcação para compostos de aminoácidos marcados com halogênio radioativo incluindo [18f]facbc, e que impeça o metanol de remanescer nos compostos de aminoácidos marcados com halogênio radioativo produzidos a partir dos mesmos. o novo composto orgânico de aminoácidos é um composto representado pela seguinte fórmula: (1) em que n é um número inteiro igual 0 ou de 1 a 4; r1 é um substituinte etila, 1-propila ou isopropila; x é um substituinte halogênio ou um grupo representado por -or2; r2 é um substituinte ácido haloalquilsulfônico de cadeia linear ou cadeia ramificada com um a 10 átomos de carbono, substituinte trialquilestanil com 3 a 12 átomos de carbono, substituinte ácido fluorsulfônico ou substituinte ácido sulfônico aromático; e r3 é um grupo protetor.
BRPI0619213A 2005-11-29 2006-11-28 composto precursor de composto orgânico marcado com haloênio radioativo BRPI0619213B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005-343653 2005-11-29
JP2005343653 2005-11-29
PCT/JP2006/323659 WO2007063824A1 (ja) 2005-11-29 2006-11-28 放射性ハロゲン標識有機化合物の前駆体化合物

Publications (3)

Publication Number Publication Date
BRPI0619213A2 BRPI0619213A2 (pt) 2011-09-20
BRPI0619213B1 BRPI0619213B1 (pt) 2018-12-26
BRPI0619213B8 true BRPI0619213B8 (pt) 2021-07-27

Family

ID=38092157

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0619213A BRPI0619213B8 (pt) 2005-11-29 2006-11-28 composto precursor de composto orgânico marcado com haloênio radioativo

Country Status (17)

Country Link
US (7) US8758724B2 (pt)
EP (2) EP3354639B1 (pt)
JP (2) JP5635225B2 (pt)
KR (3) KR20080071146A (pt)
CN (1) CN101316812A (pt)
AU (1) AU2006319987B2 (pt)
BR (1) BRPI0619213B8 (pt)
CA (1) CA2629227C (pt)
ES (1) ES2663496T3 (pt)
IL (2) IL191184A (pt)
NO (2) NO341981B1 (pt)
NZ (1) NZ568179A (pt)
PL (1) PL1978015T3 (pt)
PT (1) PT1978015T (pt)
RU (1) RU2428415C2 (pt)
TW (1) TW200800869A (pt)
WO (1) WO2007063824A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3530648B1 (en) * 2006-12-27 2023-11-08 Nihon Medi-Physics Co., Ltd Process for production of precursor compound for radioactive halogen-labeled organic compound
EP2632495A2 (en) * 2010-10-28 2013-09-04 GE Healthcare UK Limited Stabilisation of radiopharmaceutical precursors
EP2646411B1 (en) 2010-11-29 2017-08-16 Blue Earth Diagnostics Limited Preparation of pet precursor
GB201021523D0 (en) * 2010-12-20 2011-02-02 Ge Healthcare Ltd Process simplification for precursor compound
GB201021530D0 (en) * 2010-12-20 2011-02-02 Ge Healthcare Ltd Purification of precursor compound by crystallisation
MX2013007186A (es) * 2010-12-20 2013-07-12 Ge Healthcare Ltd Purificacion de compuesto precursor mediante cristalizacion.
RU2596829C2 (ru) * 2011-03-08 2016-09-10 ДжиИ ХЕЛТКЕР ЛИМИТЕД Получение производного 1-амино-3-гидроксициклобутан-1-карбоновой кислоты
WO2012171941A1 (en) 2011-06-14 2012-12-20 Ge Healthcare Limited Preparation of pet precursor
WO2013011115A1 (en) 2011-07-21 2013-01-24 Ge Healthcare Limited Precursor compounds and methods for making same
US11534494B2 (en) 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis
GB201411569D0 (en) 2014-06-30 2014-08-13 Ge Healthcare Ltd Novel formulation and method of synthesis
US20150231249A1 (en) * 2011-12-21 2015-08-20 Ge Healthcare Limited 18f-fluciclovine compositions in citrate buffers
EP3302581B1 (en) * 2015-06-04 2021-04-28 Nihon Medi-Physics Co., Ltd. Diagnostic imaging agent for early bone metastasis from cancer
MX2018009699A (es) * 2016-02-12 2019-01-24 Graphic Packaging Int Llc Caja de carton con asa.
US20200009273A1 (en) * 2017-03-07 2020-01-09 Nihon Medi-Physics Co., Ltd. Radioactive fluorine-labeled precursor compound, and method for producing radioactive fluorine-labeled compound using same

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360928A (en) * 1989-10-23 1994-11-01 Research Corporation Technologies, Inc. Synthesis and use of amino acid fluorides as peptide coupling reagents
WO1994018951A1 (en) 1993-02-23 1994-09-01 Warner-Lambert Company A process for the preparation of substantially alcohol free pharmaceutical compositions
US5808146A (en) * 1995-11-09 1998-09-15 Emory University Amino acid analogs for tumor imaging
DE69937996T2 (de) * 1998-05-15 2009-01-02 Ge Healthcare Ltd., Little Chalfont Markierte glutamin- und lysinanaloge
AU2001281121B2 (en) * 2000-08-08 2007-08-23 Ortho-Mcneil Pharmaceutical, Inc. Non-imidazole aryloxypiperidines as H3 receptor ligands
KR100540021B1 (ko) 2000-10-12 2005-12-29 쥬가이 세이야쿠 가부시키가이샤 신규한 결정 구조를 갖는 에리트로마이신 유도체 및 그의제조 방법
WO2003011345A1 (en) 2001-07-27 2003-02-13 Targesome, Inc. Lipid constructs as therapeutic and imaging agents
GB0229695D0 (en) * 2002-12-20 2003-01-29 Amersham Plc Solid-phase preparation of 18F-labelled amino acids
US7390902B2 (en) 2003-07-31 2008-06-24 Washington University Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors
WO2005030677A1 (ja) * 2003-09-30 2005-04-07 Nihon Medi-Physics Co., Ltd. 放射性フッ素化合物の製造方法
JP2008515768A (ja) * 2004-06-17 2008-05-15 エム ユー エス シー ファンデーション フォー リサーチ ディベロップメント 非天然アミノ酸
AU2006250594B2 (en) * 2005-05-23 2011-06-16 Nihon Medi-Physics Co., Ltd. Novel organic compound and method for producing radioactive halogen-labeled organic compound using the same
WO2007001940A2 (en) * 2005-06-23 2007-01-04 Emory University Imaging agents
US20060292073A1 (en) * 2005-06-23 2006-12-28 Emory University Stereoselective Synthesis of Amino Acid Analogs for Tumor Imaging
WO2007132689A1 (ja) 2006-05-11 2007-11-22 Nihon Medi-Physics Co., Ltd. 放射性フッ素標識有機化合物の製造方法
RU2445120C2 (ru) 2006-12-21 2012-03-20 Нихон Меди-Физикс Ко., Лтд. Радиоактивный агент для диагностической визуализации
EP3530648B1 (en) 2006-12-27 2023-11-08 Nihon Medi-Physics Co., Ltd Process for production of precursor compound for radioactive halogen-labeled organic compound
US8343459B2 (en) 2007-02-13 2013-01-01 Nihon Medi-Physics Co., Ltd. Method for production of radiation diagnostic imaging agent
RU2476423C2 (ru) 2007-12-19 2013-02-27 Нихон Меди-Физикс Ко., Лтд. Способ получения радиоактивного, меченного фтором органического соединения

Also Published As

Publication number Publication date
EP1978015A4 (en) 2010-08-11
EP1978015B1 (en) 2018-03-07
NO341981B1 (no) 2018-03-05
BRPI0619213B1 (pt) 2018-12-26
US20080281121A1 (en) 2008-11-13
JP5684333B2 (ja) 2015-03-11
AU2006319987B2 (en) 2012-09-06
EP3354639B1 (en) 2024-02-21
US10953112B2 (en) 2021-03-23
JP2013177468A (ja) 2013-09-09
IL235029A (en) 2016-02-29
EP3354639A1 (en) 2018-08-01
NZ568179A (en) 2010-06-25
KR101643991B1 (ko) 2016-07-29
TWI371439B (pt) 2012-09-01
US9387266B2 (en) 2016-07-12
RU2428415C2 (ru) 2011-09-10
CA2629227A1 (en) 2007-06-07
US20160000944A1 (en) 2016-01-07
US20160082135A1 (en) 2016-03-24
NO20180010A1 (no) 2008-08-25
US20140213817A1 (en) 2014-07-31
KR101608755B1 (ko) 2016-04-04
PT1978015T (pt) 2018-03-26
AU2006319987A1 (en) 2007-06-07
US9381259B2 (en) 2016-07-05
EP1978015A1 (en) 2008-10-08
US20210386873A1 (en) 2021-12-16
CN101316812A (zh) 2008-12-03
RU2008126277A (ru) 2010-01-10
KR20080071146A (ko) 2008-08-01
US10010632B2 (en) 2018-07-03
CA2629227C (en) 2014-02-25
PL1978015T3 (pl) 2018-07-31
ES2663496T3 (es) 2018-04-13
JPWO2007063824A1 (ja) 2009-05-07
KR20130101158A (ko) 2013-09-12
IL191184A (en) 2015-07-30
US20180256760A1 (en) 2018-09-13
US8758724B2 (en) 2014-06-24
BRPI0619213A2 (pt) 2011-09-20
KR20140108350A (ko) 2014-09-05
WO2007063824A1 (ja) 2007-06-07
NO20082877L (no) 2008-08-25
US11083804B2 (en) 2021-08-10
JP5635225B2 (ja) 2014-12-03
TW200800869A (en) 2008-01-01
US20200282082A1 (en) 2020-09-10

Similar Documents

Publication Publication Date Title
BRPI0619213B8 (pt) composto precursor de composto orgânico marcado com haloênio radioativo
BRPI0702269A (pt) alcanolamidas e uso do mesmo como aditivos de combustìvel
MY146951A (en) Use of polynuclear phenolic compounds as stabilisers
BR112014004313A8 (pt) Composto glicosídeo, métodos de produção de um tioéter, de éter e de composto glicosídeo, e, éter.
BRPI0818193B8 (pt) composto, composição farmacêutica, e, uso de um composto
BR112018015570A2 (pt) análogos de canabidiol biologicamente ativos
BRPI0713190B1 (pt) composto e métodos para preparar compostos
BR112012008939A2 (pt) processo para a preparação de compostos úteis como inibidores de sglt2
BR9802439A (pt) Compostos de bispirazolaza, processo para sua preparação e tinturas capilares contendo esses compostos.
BR112012028637A2 (pt) composição de gasolina, pacote de aditivo, uso de aditivo e método
BR112012018408A2 (pt) composição do combustível diesel, pacote do aditivo, uso de um aditivo e uso de uma composição do combustível diesel.
ECSP099330A (es) Compuesto de indol
BRPI0514644A (pt) composto fosforamidita, composto ácido ribonucléico, e método para produzir oligo-rna
BRPI0601216A (pt) processo para aumentar a estabilidade à oxidação de biodiesel
AR070436A1 (es) Estabilizacion de deshidrogenasas con coenzimas estables
BR112012027385A2 (pt) composição para o controle de doenças de plantas e uso da mesma
EP2213666A4 (en) AROMATIC ACID ETHER DERIVATIVE FROM LIGUSTRAZIN, METHOD OF MANUFACTURE, PHARMACEUTICAL COMPOSITION AND APPLICATION
PE20090758A1 (es) Un proceso para la preparacion de compuestos de aminodiol protegidos con oxazolina, utiles como intermediarios para florfenicol
BR0005488A (pt) Processo para a preparação de carbonato de vinileno, e o uso do mesmo
BRPI0711818A2 (pt) novo composto com afinidade pela amilóide
PA8852101A1 (es) Nucleótidos uracil ciclopropílicos
BR112012032251A2 (pt) processo para a preparação de derivados da 2, 2-difluoroetilamina pela alquilação com 2,2 difluoroetil-1-haloetanos
BR112012031314A2 (pt) "processo de preparo de compostos esteramidas"
BRPI0408300A (pt) processo para a preparação de derivados de fenetilamina
BRPI0408353A (pt) composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/12/2018, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/11/2006, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO